• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆骨保护素水平随大脑动脉粥样硬化严重程度增加。

Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis.

机构信息

Department of Neurology, Yonsei University College of Medicine, Seoul, Republic of Korea; Department of Neurology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.

Department of Neurology, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Clin Biochem. 2013 Aug;46(12):1036-1040. doi: 10.1016/j.clinbiochem.2013.05.048. Epub 2013 May 29.

DOI:10.1016/j.clinbiochem.2013.05.048
PMID:23726804
Abstract

OBJECTIVES

Osteoprotegerin (OPG) is a member of the tumor necrosis factor receptor superfamily and suggested as a marker of atherosclerosis. We investigated whether plasma OPG levels were associated with the presence and severity of cerebral atherosclerosis.

DESIGN AND METHODS

We used an enzyme-linked immunosorbent assay to measure the plasma OPG levels of 107 patients with acute cerebral infarction. We compared the plasma OPG levels according to the presence and number of arteries with cerebral atherosclerosis (≥ 50% stenosis).

RESULTS

Of 107 patients, 73 (68.2%) had cerebral atherosclerosis. OPG levels were increased in patients with cerebral atherosclerosis (374.69 ± 206.48 vs 261.17 ± 166.91 pg/mL, p=0.006). OPG levels showed positive correlation with the number of cerebral arteries with atherosclerosis (Spearman's rho=0.342, p<0.001). After adjustment for vascular risk factors, OPG>229.9 pg/mL was independently associated with the presence [OR 4.61, 95% CI 1.57-13.55, p=0.005, binary logistic regression] of cerebral atherosclerosis and number [OR 3.20, 95% CI 1.26-8.12, p=0.014, ordinal logistic regression] of arteries with cerebral atherosclerosis.

CONCLUSIONS

Plasma OPG levels were significantly associated with the presence and severity of cerebral atherosclerosis. This finding suggests that plasma OPG might have a role in cerebral atherosclerosis.

摘要

目的

骨保护素(OPG)是肿瘤坏死因子受体超家族的一员,被认为是动脉粥样硬化的标志物。我们研究了血浆 OPG 水平是否与脑动脉粥样硬化的存在和严重程度有关。

设计和方法

我们使用酶联免疫吸附试验测量了 107 例急性脑梗死患者的血浆 OPG 水平。我们根据是否存在和存在多少条有脑动脉粥样硬化(≥50%狭窄)的动脉来比较血浆 OPG 水平。

结果

在 107 例患者中,有 73 例(68.2%)有脑动脉粥样硬化。有脑动脉粥样硬化的患者 OPG 水平升高(374.69±206.48 比 261.17±166.91 pg/ml,p=0.006)。OPG 水平与有动脉粥样硬化的脑动脉数量呈正相关(Spearman's rho=0.342,p<0.001)。在调整血管危险因素后,OPG>229.9 pg/ml 与脑动脉粥样硬化的存在[比值比(OR)4.61,95%置信区间(CI)1.57-13.55,p=0.005,二项逻辑回归]和有脑动脉粥样硬化的动脉数量[OR 3.20,95%CI 1.26-8.12,p=0.014,有序逻辑回归]独立相关。

结论

血浆 OPG 水平与脑动脉粥样硬化的存在和严重程度显著相关。这一发现表明,血浆 OPG 可能在脑动脉粥样硬化中起作用。

相似文献

1
Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis.血浆骨保护素水平随大脑动脉粥样硬化严重程度增加。
Clin Biochem. 2013 Aug;46(12):1036-1040. doi: 10.1016/j.clinbiochem.2013.05.048. Epub 2013 May 29.
2
Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke.肿瘤坏死因子相关凋亡诱导配体(TRAIL)及其受体与大动脉粥样硬化性卒中的关联
PLoS One. 2015 Sep 3;10(9):e0136414. doi: 10.1371/journal.pone.0136414. eCollection 2015.
3
Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.2型糖尿病患者血浆骨保护素水平与下肢动脉疾病严重程度的关联
BMC Cardiovasc Disord. 2015 Aug 11;15:86. doi: 10.1186/s12872-015-0079-0.
4
Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.血清护骨素和肿瘤坏死因子相关凋亡诱导配体(TRAIL)在伴有白蛋白尿的 2 型糖尿病患者中升高,血清护骨素与糖尿病肾病的严重程度独立相关。
Metabolism. 2011 Aug;60(8):1064-9. doi: 10.1016/j.metabol.2010.11.002. Epub 2011 Jan 19.
5
Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease.骨保护素与内皮功能相关,并可预测冠心病患者早期颈动脉粥样硬化。
Int Heart J. 2015;56(6):605-12. doi: 10.1536/ihj.15-150. Epub 2015 Nov 9.
6
Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.入院时的血浆护骨素水平与急性 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后无复流现象及随后的左心室重构有关。
Atherosclerosis. 2012 Mar;221(1):254-9. doi: 10.1016/j.atherosclerosis.2011.12.031. Epub 2011 Dec 27.
7
The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography.心绞痛样胸痛患者行诊断性冠状动脉造影术时血清护骨素水平的价值。
Cardiol J. 2013;20(3):261-7. doi: 10.5603/CJ.2013.0071.
8
Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.在具有中等心血管风险的患者中,血浆中可溶性核因子κB受体活化因子配体(sRANKL)和骨保护素(OPG)的水平与致动脉粥样硬化细胞因子相关。
Heart Vessels. 2017 Nov;32(11):1304-1313. doi: 10.1007/s00380-017-0998-z. Epub 2017 May 31.
9
Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis.急性胰腺炎早期患者的骨保护素、肿瘤坏死因子相关凋亡诱导配体及骨保护素/肿瘤坏死因子相关凋亡诱导配体比值
Folia Med Cracov. 2014;54(2):17-26.
10
Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?骨保护素能否用于在不同临床环境中识别冠心病的存在和严重程度?
Atherosclerosis. 2014 Oct;236(2):230-6. doi: 10.1016/j.atherosclerosis.2014.07.013. Epub 2014 Jul 21.

引用本文的文献

1
Prognostic effect of osteoprotegerin in patients with ischemic stroke: A systematic review and meta-analysis.骨保护素对缺血性脑卒中患者预后的影响:系统评价和荟萃分析。
PLoS One. 2024 May 31;19(5):e0303832. doi: 10.1371/journal.pone.0303832. eCollection 2024.
2
The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods.PCSK9 抑制剂对动脉粥样硬化斑块稳定性的影响:生化和诊断影像学方法的评估。
Molecules. 2023 Aug 7;28(15):5928. doi: 10.3390/molecules28155928.
3
Plasma Concentrations of New Biochemical Markers of Atherosclerosis in Patients with Dyslipidemia-A Pilot Study.
血脂异常患者中动脉粥样硬化新生化标志物的血浆浓度:一项初步研究。
Medicina (Kaunas). 2022 May 27;58(6):717. doi: 10.3390/medicina58060717.
4
The association of plasma osteoprotegerin levels and functional outcomes post endovascular thrombectomy in acute ischemic stroke patients: a retrospective observational study.血浆护骨素水平与急性缺血性脑卒中患者血管内血栓切除术术后功能结局的相关性:一项回顾性观察研究。
PeerJ. 2022 May 3;10:e13327. doi: 10.7717/peerj.13327. eCollection 2022.
5
Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?骨桥蛋白和护骨素在动脉粥样硬化斑块中的作用——它们是斑块易损性的重要标志物吗?
Rom J Morphol Embryol. 2020 Jul-Sep;61(3):793-801. doi: 10.47162/RJME.61.3.17.
6
Plasma Osteoprotegerin Correlates with Stroke Severity and the Occurrence of Microembolic Signals in Patients with Acute Ischemic Stroke.血浆骨保护素与急性缺血性脑卒中患者的卒中严重程度和微栓子信号的发生相关。
Dis Markers. 2019 May 2;2019:3090364. doi: 10.1155/2019/3090364. eCollection 2019.
7
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.血清高迁移率族蛋白 B1 和护骨素水平与 2 型糖尿病患者的外周动脉疾病和肢体严重缺血相关。
Cardiovasc Diabetol. 2017 Aug 8;16(1):99. doi: 10.1186/s12933-017-0581-z.
8
From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease.从骨骼到血压,开发针对骨保护素途径治疗肺血管疾病的新型生物学方法。
Pharmacol Ther. 2017 Jan;169:78-82. doi: 10.1016/j.pharmthera.2016.06.017. Epub 2016 Jul 1.
9
Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke.肿瘤坏死因子相关凋亡诱导配体(TRAIL)及其受体与大动脉粥样硬化性卒中的关联
PLoS One. 2015 Sep 3;10(9):e0136414. doi: 10.1371/journal.pone.0136414. eCollection 2015.
10
Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.2型糖尿病患者血浆骨保护素水平与下肢动脉疾病严重程度的关联
BMC Cardiovasc Disord. 2015 Aug 11;15:86. doi: 10.1186/s12872-015-0079-0.